Company to spotlight clinical progress on immune
Author: Michael
Theriva Biologics announced that the Spanish Agen
Helix announced a multi-year agreement with Astra
Insilico has initiated a Phase III clinical trial
Annovis Bio Inc.
Kailera reported positive topline results from tw
As South Korea’s peptide market surges, partne
BioAge has begun iPhase 2 QUELL-CV trial, testin
Insilico’s rentosertib enters late-stage testi
Eyepoint Pharmaceuticals will participate in the